LEX Pharma Consulting
Home
About
Services
Customers
Partners
News
Contact
☎ +41(0)79 4180774
LEX Pharma Consulting
Home
About
Services
Customers
Partners
News
Contact
☎ +41(0)79 4180774

News

Regulations Updates

Nitrosamines Risk Assessment - EMA
Princesse Dell'OcaMarch 2, 2020
FDA Published a Draft Guidance on Drug Master Files
Princesse Dell'OcaMarch 2, 2020
FDA Draft Guidance on 'Quality Considerations for Continuous Manufacturing'
Princesse Dell'OcaMay 9, 2019
FDA releases the Final Guidance on Dissolution Testing and Acceptance Criteria for ImmediateRelease Solid Oral Dosage Form DP Containing High Solubility DS
Princesse Dell'OcaOctober 11, 2018
ICHQ12 Step 2b
Princesse Dell'OcaDecember 7, 2017
EMA publish an updated reflection paper on API Starting Materials
Princesse Dell'OcaNovember 5, 2017
ICH Q11 Q&A (Selection and Justification of Starting Materials) now published on ICH webpage
Princesse Dell'OcaNovember 5, 2017

Licensed in Switzerland

 

home | about | services | customers | news | contact

+41(0)79 4180774 | info@lexpharmaconsulting.com

Legal Information and Privacy Policy

 

LEX Pharma Consulting SA is a boutique business that provides CMC consulting to some of the most innovative creatives and emerging companies in the pharmaceutical industry.

Powered by Squarespace